{"title":"抑肽蛋白对冠状动脉搭桥术患者失血及心肌损害的影响","authors":"H. Wendel, W. Heller, H. Hoffmeister","doi":"10.1109/SBEC.1996.493289","DOIUrl":null,"url":null,"abstract":"High dose aprotinin therapy showed certain benefits in protecting against perioperative myocardial ischemic injury during aortic cross clamping time in patients undergoing cardiopulmonary bypass surgery. Compared with the control group significantly lower levels of the highly specific marker of cardiac injury, troponin T, could be detected.","PeriodicalId":294120,"journal":{"name":"Proceedings of the 1996 Fifteenth Southern Biomedical Engineering Conference","volume":"48 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1996-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of aprotinin on blood loss and myocardial damage in patients undergoing aortocoronary bypass surgery\",\"authors\":\"H. Wendel, W. Heller, H. Hoffmeister\",\"doi\":\"10.1109/SBEC.1996.493289\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"High dose aprotinin therapy showed certain benefits in protecting against perioperative myocardial ischemic injury during aortic cross clamping time in patients undergoing cardiopulmonary bypass surgery. Compared with the control group significantly lower levels of the highly specific marker of cardiac injury, troponin T, could be detected.\",\"PeriodicalId\":294120,\"journal\":{\"name\":\"Proceedings of the 1996 Fifteenth Southern Biomedical Engineering Conference\",\"volume\":\"48 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-03-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the 1996 Fifteenth Southern Biomedical Engineering Conference\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/SBEC.1996.493289\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 1996 Fifteenth Southern Biomedical Engineering Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/SBEC.1996.493289","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effect of aprotinin on blood loss and myocardial damage in patients undergoing aortocoronary bypass surgery
High dose aprotinin therapy showed certain benefits in protecting against perioperative myocardial ischemic injury during aortic cross clamping time in patients undergoing cardiopulmonary bypass surgery. Compared with the control group significantly lower levels of the highly specific marker of cardiac injury, troponin T, could be detected.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
